- AU$595.38m
- AU$646.73m
- $71.61m
Australia Stock Exchange release from AVITA MED CDI : Change of Director's Interest Notice-Michael Perry
Australia Stock Exchange release from AVITA MED CDI : Change of Director's Interest Notice-Suzanne Crowe
Australia Stock Exchange release from AVITA MED CDI : Results of 2021 Annual General Meeting
Australia Stock Exchange release from AVITA MED CDI : Amended and Restated Bylaws
Australia Stock Exchange release from AVITA MED CDI : Corporate Update for ASM
Australia Stock Exchange release from AVITA MED CDI : AVITA Medical Completes Enrollment in Vitiligo Pivotal Trial
Australia Stock Exchange release from AVITA MED CDI : PRE_NR Ends: 10:21:17
Australia Stock Exchange release from AVITA MED CDI : Correction of error in 2021 slide deck for ASM
Australia Stock Exchange release from AVITA MED CDI : Adjournment of 2021 Annual Stockholder Meeting
Australia Stock Exchange release from AVITA MED CDI : Corporate Update
Australia Stock Exchange release from AVITA MED CDI : 2021 Slide Deck for ASM
Australia Stock Exchange release from AVITA MED CDI : 2021 ASM Chairman Script
Australia Stock Exchange release from AVITA MED CDI : Form 8-K
Australia Stock Exchange release from AVITA MED CDI : Statement of CDIs on issue - AVH
Australia Stock Exchange release from AVITA MED CDI : Form 8-K
Australia Stock Exchange release from AVITA MED CDI : Notice under section 708A(5)(e) of the Corporations Act
Australia Stock Exchange release from AVITA MED CDI : Notification regarding unquoted securities - AVH
Australia Stock Exchange release from AVITA MED CDI : Notification of cessation of securities - AVH
Australia Stock Exchange release from AVITA MED CDI : Becoming a substantial holder